ClinicalTrials.gg
RecruitingNCT06501092Updated Jun 26, 2026

To Assess the Utility of the Point Mini in a Clinical Take-home Study

An interventional study of Point Mini in Amputation; Traumatic, Hand and Amputation, Congenital, sponsored by Point Designs. Recruiting at 2 sites in United States. Open to participants aged 3 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by Point Designs · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Non-randomized
Ages
3 Years to 17 Years
Sex
All
01

Study summary

The objective of this study is to evaluate the efficacy of the Point Mini system as compared to the subject's existing prosthetic treatment, which may include a prosthesis, other assistive device, or no device. This study will be a single subject crossover design where one group of 14 children with partial hand deficiencies will be evaluated on several metrics using their existing prosthetic treatment for one month and the Point Mini system for two months. Metrics include: in-clinic functional measures, subjective assessments, bilateral hand use, and prosthesis wear time.

02

Conditions studied

  • Amputation; Traumatic, Hand
  • Amputation, Congenital
03

In context

Lead sponsor

Point Designs is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 5 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unilateral or bilateral partial hand limb differences
  • Fluent in English or Spanish
  • Ability to follow simple directions
  • Age between 3 and 17 years

Exclusion criteria

Exclusion Criteria:

  • Patients with any unhealed wounds on their residual limb(s)
  • Significant cognitive deficits as determined upon clinical evaluation
  • Inability to follow simple directions
  • Significant physical deficits including pain and scarring impacting the design and fitting of the Point Mini prosthesis
  • Other psychosocial, personal, and medical co-morbidities expressed by the subject, family or study personnel
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
14 participants (estimated)

Study arms

  • No intervention
    Current/No Device

    Baseline outcome measurements will be performed with subject's existing partial hand prosthetic treatment, as deemed standard-of-care by the patient's prosthetist. Device types include, but are not limited to, no prosthesis, passive prosthesis, passive positional prosthesis, body-powered prosthesis, myoelectric prosthesis, or other assistive device.

  • Experimental
    Point Mini

    Outcome measurements will be performed \~60 days after the subject has been fit with a prosthesis, with additional visits occurring immediately post-fitting and \~30 days post-fitting.

    Device: Point Mini

Interventions

  • DevicePoint Mini

    Patient is fit with the Point Mini finger prosthetic system, which consists of 1-4 ratcheting mechanical digits and mounting brackets

06

What researchers measure

Primary outcomes

  1. Prosthetic Upper Extremity Functional Index - 2 (PUFI - 2)

    The PUFI-2 is a measure of manual ability for children with upper limb impairment with and without a prosthesis. PUFI-2 consists of a questionnaire listing 23-27 manual activities and asks how the child performs the activity, how difficult it is to complete, and whether the prosthesis is useful or not. Both self-report and parent proxy-report versions are available.

    Time frame: Baseline (pre-fitting), 60 days post-fitting

  2. PROMIS Pediatric - Upper Extremity Short Form (PROMIS Ped - UE)

    The PROMIS Ped - UE is a questionnaire that measures upper extremity physical function specifically in children. Both self-report and parent proxy-report versions are available.

    Time frame: Baseline (pre-fitting), 60 days post-fitting

Secondary outcomes

  1. Weekly Diary Entries

    Throughout the study, subjects and their parents will fill out weekly logs asking their experiences during the day, number of hours wearing the device, descriptions of the tasks performed, and open-response sections to clarify/detail any other events. The weekly logs will be in sealed envelopes and not opened until the completion of the study by the experimenters.

    Time frame: Through study completion, an average of 3 months

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2025 (actual). Primary completion is estimated for Jul 2027, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 5, 2024
First posted
Jul 15, 2024
StartActual
Jun 18, 2025
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06501092
Lead sponsor
Point Designs
Responsible party
Sponsor
First posted
Jul 15, 2024
Start date
Jun 18, 2025
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jun 26, 2026

Study contacts

Rebecca Connolly
Contact
becca@pointdesigns.com
720-600-4753
Levin Sliker, PhD
Contact
levin@pointdesigns.com
720-600-4753
Levin Sliker, PhD
principal investigator · Point Designs

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion